Fennec Pharmaceuticals (FENC) Debt Ratio (2021 - 2022)
Fennec Pharmaceuticals (FENC) posted Debt Ratio of 0.93 for Q4 2022, up 12.91% on a QoQ basis from 0.82 in Q3 2022, and up 204.42% year-over-year from 0.3 in Q4 2021.
Fennec Pharmaceuticals (FENC) Debt Ratio (2021 - 2022) Analysis & Trends
Fennec Pharmaceuticals' Debt Ratio history runs 2 years deep, the most recent figure standing at 0.93 for Q4 2022.
- Quarterly Debt Ratio rose 204.42% year-over-year to 0.93 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was 0.93 (up 204.42% YoY) and the FY2022 annual result came in at 0.93, up 204.42% from the prior year.
- Debt Ratio was 0.93 for Q4 2022 at Fennec Pharmaceuticals, up from 0.82 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.93 in Q4 2022 and bottomed at 0.07 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 0.93 |
| Sep 30, 2022 | 0.82 |
| Jun 30, 2022 | 0.32 |
| Mar 31, 2022 | 0.26 |
| Dec 31, 2021 | 0.30 |
| Sep 30, 2021 | 0.07 |
| Jun 30, 2021 | 0.07 |